n.zielinski

TL2 · Nairobi

Contributes reviews on supplier material. Based in Nairobi.

Joined 21 May 2025 · last posted 18h

81 posts, newest first. Showing up to 150.

Stability of BPC-157 in solution: what has been measured — one year on Replied, post #99 · Compounds › Repair & healing peptides · 27 Jul 2026 · 11 likes The arithmetic on Stability of BPC-157 is the easy part and it is where the errors are, which is an uncomfortable combination. Show your working and someone will catch…
Coming back to: A structured critique template this community uses Replied, post #69 · Evidence › Study critique · 26 Jul 2026 · 4 likes Whatever the answer on structured critique template turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public, invite…
Transit times by route, from a logged dataset Replied, post #29 · Sourcing › Logistics · 23 Jul 2026 · 7 likes An update on my earlier transit times post: the pattern held for another six weeks and then stopped, which I did not predict and cannot explain.
What a certificate commits its issuer to Replied, post #80 · Analytics › COA interpretation · 22 Jul 2026 · 21 likes I had written a reply contradicting post #76 and deleted it. Here is what survived. The distinction between release testing and characterisation is one industrial…
Coming back to: Preparing for an appointment: one page, three questions Replied, post #18 · Clinical › Prescriber conversations · 19 Jul 2026 · 1 like A question phrased as "what would you want to see before considering X" is answerable and is not a request for X.
Here for the analytics and not much else Replied, post #52 · Lounge › Introductions · 18 Jul 2026 · 23 likes Community culture: introductions give you a sense of who is here. Reading a few introduces you to the people and the tone of the community.
What a reversed-phase purity number actually is Replied, post #65 · Analytics › HPLC & UHPLC · 17 Jul 2026 · 6 likes This is why a purity figure without the underlying chromatogram is weaker evidence than it appears. It is also why two competent laboratories can report different…
PIONEER 6 cardiovascular safety, read as a safety trial rather than an efficacy one Replied, post #4 · Compounds › Oral incretins · 17 Jul 2026 · 22 likes Trial adherence in an oral trial with strict administration requirements is genuinely worse than trial-published data often suggests. That is why the exposure…
Coming back to: Lateral-flow and colorimetric approaches: the specificity problem Replied, post #79 · Analytics › Home & field testing · 17 Jul 2026 · 3 likes Where I part company with post #77, and it is a narrow parting. Photographs of test results posted here are worth including with the lighting and the timing stated,…
Priming a pen and whether the primed volume is wasted Replied, post #9 · Devices › Pens & autoinjectors · 17 Jul 2026 · 31 likes Answering the question post #5 raises rather than the one it answers. Disposal of a used pen is a sharps question even where the needle is retracted, and local rules…
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #125 · Practice › Reconstitution · 15 Jul 2026 · 18 likes Narrowing post #123, because the general version has more than one answer. Two people can reconstitute the same vial to different concentrations and both be right. The…
The anatomy of a question that gets answered within an hour — does this still hold? Replied, post #19 · Start Here › How to Ask · 13 Jul 2026 · 20 likes Second this, and I would have said it less carefully.
CJC-1295 with and without DAC: what the modification does Replied, post #100 · Compounds › Secretagogues & GH axis · 2 Jul 2026 · 0 likes If someone has run CJC-1295 properly I would rather read that than my own reconstruction of it. Posting mine only because the thread has gone quiet.
Talking to a therapist about this specifically Replied, post #15 · Wellbeing › Mental health · 23 Jun 2026 · 10 likes Coming back to post #13, because the follow-up matters more than the original answer. Where a member is finding this hard, the useful reply is usually a question rather…
A pooled estimate that changed when one trial was added Replied, post #8 · Evidence › Meta-analyses · 10 Jun 2026 · 8 likes A request rather than an answer: could whoever has the primary source for pooled estimate post it? I have seen the claim three times this month and each version had…
A site rotation scheme that is easy enough to actually follow Replied, post #74 · Practice › Administration · 28 May 2026 · 3 likes Adding the measurement that post #73 says would settle it. Distinguishing three things in the site rotation scheme discussion that keep getting used interchangeably:…
[2026 update] Storing lyophilised material long term: what governs the shelf life Replied, post #120 · Practice › Storage & stability · 22 May 2026 · 0 likes This follows post #119 rather than contradicting it. Trying to state the Storing lyophilised material long term position in a way that someone who disagrees would…
Revisiting: Patterns that reliably precede a problem, documented Replied, post #2 · Sourcing › Red flags · 18 May 2026 · 0 likes Screenshots without provenance are the weakest form of evidence circulating here, and they travel further than anything better documented. It cost nothing to check and…
Revisiting: A field-by-field walk through a certificate of analysis Replied, post #26 · Analytics › COA interpretation · 2 May 2026 · 18 likes Post #25 is the version of this I will quote in future. One addition. On field-by-field walk through a certificate I would separate what is worth knowing from what is…
Coming back to: Half-life, steady state, and accumulation worked through Replied, post #13 · Pharmacology › Pharmacokinetics · 11 Apr 2026 · 1 like Loading doses are not used in this class and the pharmacokinetic reason is tolerability rather than efficacy. A loading dose would reach steady state faster and would…
Spike-and-recover accuracy for a peptide assay Replied, post #67 · Analytics › Method validation · 9 Apr 2026 · 5 likes Post #66 answers the question as asked. The question underneath it is different. The claim about spike-and-recover accuracy upthread is stronger than its source…
Sample handling between despatch and injection Replied, post #11 · Analytics › Method validation · 1 Apr 2026 · 10 likes Post #9 answers the question as asked. The question underneath it is different. Sample handling between despatch is well covered in the tag pages, and the older…
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #85 · Pharmacology › Pharmacokinetics · 27 Mar 2026 · 15 likes A pharmacokinetic model fitted to trial data describes the population studied. Applying it to somebody outside the enrolled range is an extrapolation, and the model…
Revisiting: The report format the maintainers ask for, and why each field is there Replied, post #35 · Sourcing › Vendor reports · 14 Mar 2026 · 6 likes The maintainers will ask for missing fields rather than rejecting a report. Filling them in afterwards is normal and nobody minds.
[2026 update] Composite endpoints and the component doing the work Replied, post #21 · Evidence › Trials · 6 Mar 2026 · 13 likes Composite endpoints looks different depending on whether you are reading the primary literature or the summaries of it, and the difference is not in our favour.
The lowest dose that does anything: is that a real question? Replied, post #56 · Practice › Dosing & titration · 5 Mar 2026 · 19 likes How the published trials escalated: they used specific step sizes and intervals. The STEP programme used a particular cadence; the SURPASS and SURMOUNT programmes used…
Rotating between abdomen, thigh and upper arm: absorption differences Replied, post #2 · Practice › Administration · 19 Feb 2026 · 3 likes Injecting into an area that has become firm: lipohypertrophy — thickened fatty tissue from repeated injection in one area — changes local tissue absorption. Avoid…
Heterogeneity as information rather than as a nuisance Replied, post #92 · Evidence › Meta-analyses · 6 Feb 2026 · 9 likes Building on post #89 rather than restating it. Careful with the language on heterogeneity. "Not detected" and "not present" are different findings and the first is a…
Revisiting: Language barriers in accessing a prescription abroad Replied, post #82 · Access › International · 30 Jan 2026 · 12 likes Language matters for finding primary sources. The authoritative document is usually not in English and the translation usually is not authoritative. Worth checking…
Second pass at: Pregnancy and pregnancy planning: contraindication and washout Replied, post #13 · Clinical › Special populations · 21 Jan 2026 · 3 likes Post #11 answers the question as asked. The question underneath it is different. Post-surgical populations, particularly after procedures affecting the gastrointestinal…
Muscle cramps: the ordinary causes before the exotic ones Replied, post #80 · Practice › Side effects · 20 Jan 2026 · 0 likes Muscle cramps has been discussed here with more heat than it deserves, mostly because two definitions have been in play the whole time.
Muscle cramps: the ordinary causes before the exotic ones Replied, post #7 · Practice › Side effects · 12 Jan 2026 · 13 likes Understood. Thank you for being specific about the limits of it.
Coming back to: Private prescribing in the UK: what is actually involved Replied, post #46 · Regional › UK & Ireland · 7 Jan 2026 · 27 likes Source for the Private prescribing figure, since it was asked for. It is in the discussion rather than the abstract, which is why the version circulating is stronger…
Reverse causation in a cohort study of weight and outcome Replied, post #7 · Evidence › Study critique · 29 Dec 2025 · 0 likes The arithmetic in post #6 is right; the assumption feeding it is the part to check. Statistical significance and clinical importance are different and both are needed.…
Dose numbers for oral formulations are not comparable to injectable ones Replied, post #14 · Compounds › Oral incretins · 19 Dec 2025 · 21 likes Taking post #11 at face value and following it one step further. Tablet integrity matters more than people expect for a formulation that depends on an absorption…
Coming back to: The SOUL trial and oral semaglutide cardiovascular outcomes Replied, post #75 · Compounds › Oral incretins · 18 Dec 2025 · 7 likes Research-use-only oral material is not a licensed tablet and there is no reason to assume it carries a functioning absorption-enhancement system at all. The formulation…
Gastro-oesophageal reflux: improving or worsening? Replied, post #3 · Clinical › Comorbidities · 5 Dec 2025 · 13 likes Nothing here is medical advice and clinicians posting in this subcategory say so on their own account rather than because a rule requires it.
Non-inferiority margins: how they are chosen and how they are abused Replied, post #20 · Evidence › Trials · 1 Dec 2025 · 2 likes The arithmetic in post #17 is right; the assumption feeding it is the part to check. Where the non-inferiority margins discussion usually stalls is that nobody wants to…
The 2.5 mg starting dose is not a therapeutic dose — why that matters — a second dataset Replied, post #9 · Compounds › Tirzepatide · 1 Dec 2025 · 29 likes Agreed on all of that, and I have nothing to add to it.
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one Replied, post #37 · Compounds › Oral incretins · 9 Nov 2025 · 1 like Picking up post #36: that is the part I would want checked first. Orforglipron is a small molecule rather than a peptide, which changes almost everything about how it…
Reconciling a supplier certificate with an independent result Replied, post #21 · Sourcing › Vendor reports · 3 Nov 2025 · 27 likes What "verified" means on our pages: specific lots were independently measured on stated dates by named services and results were consistent with the supplier's…
SURMOUNT-4 and what withdrawal data does and does not tell an individual — one year on Replied, post #128 · Compounds › Tirzepatide · 24 Oct 2025 · 0 likes Since SURMOUNT-4 keeps coming up, it should probably be a maintained page rather than a recurring thread. I am happy to draft it if someone with more direct experience…
Sleep tracking data and its considerable limitations Replied, post #69 · Wellbeing › Sleep · 23 Oct 2025 · 3 likes I had written a reply contradicting post #67 and deleted it. Here is what survived. Stimulants and sleep: if supplementing with caffeine or other stimulants for energy…
Research-use-only labelling: what it means and what it does not Replied, post #48 · Sourcing › Regulatory · 20 Oct 2025 · 30 likes Coming back to post #46, because the follow-up matters more than the original answer. What I can speak to on research-use-only labelling is narrow, so I will keep it…
Follow-up: Why appetite effects are mostly central Replied, post #66 · Pharmacology › Receptor biology · 13 Oct 2025 · 10 likes Small methodological point on appetite effects: repeating a measurement is cheap and resolves most of what is being argued about here at no cost to anyone.
Aggregated purity results across four services, with caveats — a second dataset Replied, post #152 · Data & Tools › Datasets · 11 Sep 2025 · 12 likes Picking up post #151: that is the part I would want checked first. Practical answer on Aggregated purity results across four, since the theoretical one is upthread: do…
Managing an unplanned gap in supply — what changed since Replied, post #56 · Access › Shortages · 7 Sep 2025 · 19 likes This follows post #55 rather than contradicting it. Supply interruptions: official shortage notices are published by regulatory agencies. That is the correct primary…
When a preprint is the best available evidence and we say so Replied, post #133 · Evidence › Preprints · 3 Sep 2025 · 2 likes The arithmetic on preprint is the easy part and it is where the errors are, which is an uncomfortable combination. Show your working and someone will catch it.
Second pass at: Why this subcategory is stricter about sourcing than most Replied, post #103 · Compounds › Secretagogues & GH axis · 27 Aug 2025 · 0 likes Building on post #102 rather than restating it. Injection-site reactions are reported more often in this family than for the incretins. Whether that is the compounds or…
Semaglutide versus liraglutide head to head: reading STEP 8 carefully Replied, post #39 · Compounds › Semaglutide · 9 Aug 2025 · 1 like Solutions of semaglutide can look faintly opalescent without anything being wrong. Visible particulate, fibres or frank cloudiness are a different observation entirely…
Follow-up: Journal club: orforglipron phase 2 and the non-peptide question Replied, post #7 · Evidence › Journal club · 8 Aug 2025 · 1 like Confirming post #4 from a second method, which matters more than confirming it from a second person. The baseline characteristics table is the single most useful page…
A ten-fold dose error caught before injection — one year on Replied, post #119 · Devices › Syringes & needles · 4 Aug 2025 · 12 likes Agreed on all of that, and I have nothing to add to it.
The C-cell question: rodent findings and their human context Replied, post #44 · Compounds › Semaglutide · 28 Jul 2025 · 30 likes Two questions I would want answered before drawing anything from the c-cell question data above: how were the cases selected, and what happened to the ones that dropped…
Thyroid function tests during substantial weight change Replied, post #13 · Clinical › Bloodwork · 25 Jul 2025 · 1 like I had written a reply contradicting post #9 and deleted it. Here is what survived. A trend needs at least three points to be a trend. Two points are a line and a line…
Substitution between formats during a shortage Replied, post #25 · Access › Shortages · 19 Jul 2025 · 0 likes Trying to state the substitution between formats position in a way that someone who disagrees would recognise as fair, because I do not think the version in this thread…
Regression to the mean in progress reports Replied, post #30 · Research Methods › Statistics · 8 Jul 2025 · 27 likes On regression, I would rather understate and be corrected upward than overstate and be quoted. That is a house style here and it is a good one.
Thyroid function tests during substantial weight change Started this topic · Clinical › Bloodwork · 4 Jul 2025 · 0 likes Posting this under the heading it deserves: Thyroid function tests during substantial weight change Everything below is what sits behind that. I was wrong about thyroid…
Subcutaneous absorption kinetics and site differences Replied, post #12 · Pharmacology › Pharmacokinetics · 1 Jul 2025 · 1 like Fasting requirement for oral semaglutide: food and large fluid volumes reduce absorption. The fasting window (30 minutes before and 30 minutes after) is designed to…
Repeatability versus intermediate precision Replied, post #93 · Analytics › Method validation · 29 Jun 2025 · 20 likes Speaking only to repeatability versus intermediate precision as I have actually seen it, rather than as it is usually described: the effect is real, it is smaller than…
Comparators chosen for regulatory reasons rather than clinical ones — one year on Replied, post #53 · Evidence › Trials · 15 Jun 2025 · 7 likes Non-inferiority margins are chosen, and the choice is an argument rather than a fact. A wide margin can make a worse treatment look acceptable.
Validating a calculator against hand arithmetic — what changed since Replied, post #130 · Data & Tools › Calculators · 12 Jun 2025 · 0 likes Picking up post #127: that is the part I would want checked first. Titration planning: a calculator that shows you the escalation schedule for different starting and…
What a documentation review can and cannot tell you Replied, post #3 · marked as the solution · Sourcing › Independent verification · 10 Jun 2025 · 7 likes Verified here means specific lots were independently measured on stated dates by named services and the results were consistent with the documentation. It is narrower…
Reading a regulatory notice rather than an article about it — what changed since Replied, post #11 · Sourcing › Regulatory · 1 Jun 2025 · 4 likes If you can confirm or contradict a position for your own region, please date the answer. An undated regional claim is the least useful thing in this category. I would…
Splitting a vial for two laboratories: how to do it without ruining both Replied, post #47 · Sourcing › Independent verification · 26 May 2025 · 8 likes Post #46 describes the usual case. This is about the unusual one. On splitting a vial, the part that usually goes wrong is that the question is asked as though it has…
Storing a pen in use versus a pen unopened Replied, post #15 · Devices › Pens & autoinjectors · 21 May 2025 · 0 likes A pen delivers a fixed or dialled dose from a cartridge and is a metering device rather than simply a covered syringe. That is why dose changes are constrained to…
Journal club: STEP 4 and what a withdrawal design can prove Replied, post #42 · Evidence › Journal club · 20 May 2025 · 0 likes Sessions on negative or null results are consistently the most instructive and the hardest to get anyone to attend.
Coverage for the indication versus for the drug Replied, post #57 · Access › Insurance & coverage · 8 May 2025 · 13 likes The arithmetic in post #56 is right; the assumption feeding it is the part to check. Keep every document with dates in one place. An appeal months later is assembled…
Carryover and the ghost peak from last week's standard Replied, post #32 · Analytics › HPLC & UHPLC · 5 Apr 2025 · 14 likes Second-hand on carryover, so weight it accordingly — someone whose method I trust told me this and I have not verified it myself.
Coming back to: An 18-month record including the parts that went badly Replied, post #34 · Outcomes › Progress reports · 1 Apr 2025 · 2 likes A single scale used throughout beats a more accurate scale introduced halfway through. Consistency beats accuracy for a trend. That matches what I was told, which is…
Counter-ion content and its effect on measured mass Replied, post #9 · Analytics › Mass spectrometry · 1 Apr 2025 · 13 likes Common adducts: sodium adds ≈22, potassium adds ≈38 compared to hydrogen. A [M+Na]+ peak is common and its mass is predictable from the base mass. That is all I can say…
Random versus fixed effects: choosing rather than defaulting — a second dataset Replied, post #36 · Evidence › Meta-analyses · 1 Feb 2025 · 24 likes The useful distinction on Random versus fixed effects is between what was measured and what was inferred from it. Both end up in the same sentence and only one of them…
When "no data" is the complete and final answer Replied, post #75 · Compounds › Other compounds · 25 Jan 2025 · 24 likes Compounds this community declines to help with, and why: there are specifics in the guidelines and they are not arbitrary. They exist because of failure modes that have…
Second pass at: Certificates issued by the seller versus by a laboratory Replied, post #54 · Analytics › COA interpretation · 25 Jan 2025 · 3 likes This is the first time the answer has come with its own limits attached. Appreciated.
Molecular mass of semaglutide and why the figure differs between sources — does this… Replied, post #49 · Compounds › Semaglutide · 21 Dec 2024 · 12 likes Injection site does not appear to matter much for semaglutide exposure. The published comparisons of abdomen, thigh and upper arm found differences small enough to be…
Reading a preclinical wound-healing model and its relevance to a human tendon Replied, post #131 · Compounds › Repair & healing peptides · 24 Nov 2024 · 22 likes Right, and stated more narrowly than I would have dared to state it.
Requesting a page: what makes a good request — what changed since Replied, post #47 · Documentation › Wiki requests · 10 Oct 2024 · 5 likes Post #44 is the version of this I will quote in future. One addition. Format suggestions: if you think a maintained page could be clearer in its presentation (different…
The C-cell question: rodent findings and their human context — what changed since Replied, post #41 · Compounds › Semaglutide · 8 Sep 2024 · 26 likes Post #38 and I disagree about the size of the effect, not about the direction. Gastric emptying delay is the mechanism behind most of the gastrointestinal side effects.…
The mass-error checker and its intended scope Replied, post #120 · Data & Tools › Calculators · 13 Jul 2024 · 0 likes Post #118 is the version of this I will quote in future. One addition. The parts-per-million mass-error calculation is simple enough to do mentally to one significant…
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #106 · Practice › Dosing & titration · 9 Jul 2024 · 0 likes The practical version of Splitting a weekly dose is three sentences long. The rigorous version is three pages and reaches the same conclusion with the conditions…
The mass-error checker and its intended scope Replied, post #97 · Data & Tools › Calculators · 4 Jul 2024 · 22 likes Adding a null result on mass-error checker. I looked, carefully, and found nothing, and null results deserve posting precisely because they never are.
How this community labels and discusses unrefereed work Replied, post #40 · Evidence › Preprints · 25 Jun 2024 · 0 likes Unrefereed work is not worthless. A great deal of it survives review substantially unchanged. It is also the case that the version appearing in a journal frequently has…